New study aims to catch pancreatic cancer early in High-Risk groups
NCT ID NCT06330441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people at high risk of pancreatic cancer, such as those with a strong family history or certain genetic conditions. Researchers will use MRI and endoscopic ultrasound to screen participants regularly and see which method works best. The goal is to detect cancer earlier, when treatment may be more effective. About 700 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Masaryk Memorial Cancer Institute
RECRUITINGBrno, 65653, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an arthritis drug quiet the pain of chronic pancreatitis?
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- A sound wave that could expose hidden pancreatic cancer?